Bone Mass Continues to Increase at the Hip After Parathyroid Hormone Treatment Is Discontinued in Glucocorticoid-Induced Osteoporosis: Results of a Randomized Controlled Clinical Trial
Year: 2000
Type: article
Study design: Clinical Trial
Authors: Nancy E. Lane, Sarah Sanchez, Gunnar W. Modin, Harry K. Genant, Elena Pierini, Claude D. Arnaud
Institution: University of California, San Francisco
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: glucocorticoid-induced osteoporosis, parathyroid hormone (1-34), bone mineral density, postmenopausal women, hormone replacement therapy, bone turnover markers, lumbar spine, femoral neck, estrogen-only therapy, glucocorticoid withdrawal, treatment discontinuation, secondary osteoporosis, quantitative computed tomography, dual-energy X-ray absorptiometry
Open Access status: closed
Funder: U.S. Public Health Service
Award: G7485603202
OpenAlex ID: W2029198743
